| Revenue | 23/02/2019 | 24/02/2018 | 25/02/2017 | 27/02/2016 |
| Total revenue | 63,182,000 | 56,820,000 | 55,295,000 | 53,357,000 |
| Cost of revenue | 59,664,000 | 54,099,000 | 52,932,000 | 51,184,000 |
| Gross profit | 3,518,000 | 2,721,000 | 2,363,000 | 2,173,000 |
| Operating expenses |
| Research development | - | - | - | - |
| Selling general and administrative | 1,416,000 | 1,085,000 | 1,190,000 | 1,367,000 |
| Non-recurring | - | - | - | - |
| Others | - | - | - | - |
| Total operating expenses | 61,080,000 | 55,184,000 | 54,122,000 | 52,551,000 |
| Operating income or loss | 2,102,000 | 1,636,000 | 1,173,000 | 806,000 |
| Income from continuing operations |
| Total other income/expenses net | -428,000 | -336,000 | -1,028,000 | -604,000 |
| Earnings before interest and taxes | 2,102,000 | 1,636,000 | 1,173,000 | 806,000 |
| Interest expense | -294,000 | -400,000 | -513,000 | -480,000 |
| Income before tax | 1,674,000 | 1,300,000 | 145,000 | 202,000 |
| Income tax expense | 354,000 | 306,000 | 87,000 | -54,000 |
| Minority interest | -24,000 | -22,000 | -24,000 | -10,000 |
| Net income from continuing ops | 1,320,000 | 994,000 | 58,000 | 256,000 |
| Non-recurring events |
| Discontinued operations | - | 216,000 | -112,000 | -127,000 |
| Extraordinary items | - | - | - | - |
| Effect of accounting changes | - | - | - | - |
| Other items | - | - | - | - |
| Net income |
| Net income | 1,322,000 | 1,208,000 | -40,000 | 138,000 |
| Preferred stock and other adjustments | - | - | - | - |
| Net income applicable to common shares | 1,322,000 | 1,208,000 | -40,000 | 138,000 |